A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer
A phase 2 trial of HS-20093, Rezvilutamide, Abiraterone acetate in prostate cancer, run by Jiangsu HengRui Medicine Co., Ltd., now recruiting.
Overview
A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer is a phase 2 interventional study registered as NCT07230106 by Jiangsu HengRui Medicine Co., Ltd., with 218 participants planned, started 2025-12-08 and due to reach its primary completion in 2028-12. Interventions recorded: HS-20093 for Injection, SHR3680 Tablet, Abiraterone Tablet, SHR2554 Tablet, Enzalutamide Tablet. Conditions listed: Prostate Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Shares Rezvilutamide, Jiangsu Hengrui Pharmaceuticals, Prostate cancer.
- TrialA Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer
Shares Rezvilutamide, Jiangsu Hengrui Pharmaceuticals, Prostate cancer.
- TrialAn Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Canc
Shares Enzalutamide, Abiraterone acetate, Prostate cancer.
- TrialA Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Ver
Shares Abiraterone acetate, Jiangsu Hengrui Pharmaceuticals, Prostate cancer.
- TrialA Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
Shares Enzalutamide, Abiraterone acetate, Prostate cancer.
- TrialA Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA
Shares Enzalutamide, Abiraterone acetate, Prostate cancer.
- TrialAbiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Shares Enzalutamide, Abiraterone acetate, Prostate cancer.
- TrialA Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Shares Enzalutamide, Abiraterone acetate, Prostate cancer.